Acceptability and Feasibility of Injectable Cabotegravir Pre-exposure Prophylaxis (PrEP) Versus Oral PrEP in Routine Care up to 15 Months in Private Pharmacies in South Africa
Clinical trial NCT06138600 · UNKNOWN
Trial details
- NCT number
- NCT06138600
- Sponsor
- University of Witwatersrand, South Africa
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-01
- Primary completion
- 2025-10-31
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.